|
|
Volumn 6, Issue 23, 2015, Pages 19346-19347
|
|
Cytokine treatment in cancer immunotherapy
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYTOKINE;
INTERLEUKIN 2;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;
MITOGEN ACTIVATED PROTEIN KINASE 1;
MITOGEN ACTIVATED PROTEIN KINASE 3;
PROTEIN KINASE B;
CANCER IMMUNOTHERAPY;
CELL MOTILITY;
CLINICAL EFFECTIVENESS;
DRUG EFFICACY;
DRUG RESPONSE;
EDITORIAL;
HUMAN;
IMMUNE RESPONSE;
LYMPHOCYTE FUNCTION;
MALIGNANT NEOPLASTIC DISEASE;
MOLECULAR DYNAMICS;
NATURAL KILLER CELL;
NONHUMAN;
PROTEIN DETERMINATION;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
TARGET CELL DESTRUCTION;
TUMOR CELL;
ANIMAL;
IMMUNOLOGY;
IMMUNOTHERAPY;
MOUSE;
NEOPLASMS;
PROCEDURES;
ANIMALS;
CYTOKINES;
HUMANS;
IMMUNOTHERAPY;
KILLER CELLS, NATURAL;
MICE;
NEOPLASMS;
|
|
EID: 84939240568
PISSN: None
EISSN: 19492553
Source Type: Journal
DOI: 10.18632/oncotarget.5095 Document Type: Editorial |
|
Times cited : (20)
|
|
References (7)
|
